Skip to main content
. 2024 Jul 2;10(14):e33903. doi: 10.1016/j.heliyon.2024.e33903

Table 2.

Meta-analysis of the association between KIR genes and susceptibility to ulcerative colitis.

Gene Qualified studies Cases (n/N) Controls (n/N) OR (95 % CI) z- test P pc Publication bias
Heterogeneity
Effect model
E L R B& M T PQ I2
KIR2DL1 6 581/622 1453/1485 0.501 (0.302–0.832) −2.672 0.131 1.000 0.851 0.550 0.167 38.20 FEM
KIR2DL2 6 263/622 690/1485 0.937 (0.600–1.464) −0.285 0.776 1.000 0.851 0.866 0.002 73.28 REM
KIR2DL3 6 524/622 1352/1485 0.530 (0.317 to 0.886) −2.420 0.015 0.540 0.851 0.490 0.036 58.08 REM
KIR2DL5 6 310/622 750/1485 1.101 (0.803–1.510) 0.598 0.550 1.000 0.573 0.447 0.056 53.55 REM
KIR2DS1 5 246/522 583/1379 1.243 (1.002 to 1.543) 1.976 0.048 1.000 0.327 0.108 0.170 37.70 FEM
KIR2DS2 5 258/522 656/1379 1.131 (0.904–1.417) 1.077 0.281 1.000 1.000 0.646 0.231 28.54 FEM
KIR2DS3 5 171/522 397/1379 1.279 (1.016 to 1.610) 2.099 0.036 1.000 0.624 0.444 0.156 39.77 FEM
KIR2DS4 3 364/395 746/791 0.675 (0.325–1.401) −1.055 0.291 1.000 0.602 0.531 0.096 57.28 REM
KIR2DS4full 2 45/127 386/588 0.554 (0.324 to 0.947) −2.161 0.031 1.000 - - 0.544 0.00 FEM
KIR2DS5 4 141/411 343/1129 1.313 (0.764–2.257) 0.985 0.324 1.000 0.497 0.333 0.006 75.75 REM
KIR3DL1 6 588/622 1414/1485 0.847 (0.550–1.303) −0.758 0.449 1.000 0.573 0.371 0.657 0.00 FEM
KIR3DS1 5 236/522 577/1379 1.151 (0.931–1.422) 1.299 0.194 1.000 0.327 0.243 0.235 27.93 FEM

KIR: Killer Immunoglobulin-like Receptor; OR: Odds Ratio; 95 % CI: 95 % Confidence Interval; FEM: Fixed-Effect Model; REM: Random-Effect Model; n/N: number of carriers a certain KIR/total; B & M T: Begg and Mazumdar test; E L R: Egger's linear regression.